Grants and Contributions:
Title:
Artificial Intelligence (AI)-based system for drug profiling
Agreement Number:
948869
Agreement Value:
$122,040.00
Agreement Date:
May 1, 2020 - May 31, 2021
Description:
The firm is building an artificial intelligence-based system which would be used to computationally profile drug candidates against multiple protein kinases simultaneously. The goal is to dramatically increase the efficiency of drug target screening.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6T 1W5
Reference Number:
172-2020-2021-Q1-948869
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
766039887
Recipient Type:
For-profit organization
Recipient's Operating Name:
Pharmasilico
Recipient's Legal Name:
Pharmasilico Technologies Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710